NeuroPace, Inc. (NPCE)
13.99
-0.04
(-0.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.99
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Debt to Equity Ratio : 5.885 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.885 |
| March 31, 2026 | 4.875 |
| December 31, 2025 | 3.722 |
| September 30, 2025 | 3.844 |
| June 30, 2025 | 3.679 |
| March 31, 2025 | 3.014 |
| December 31, 2024 | 9.152 |
| September 30, 2024 | 7.482 |
| June 30, 2024 | 7.452 |
| March 31, 2024 | 5.096 |
| December 31, 2023 | 3.505 |
| September 30, 2023 | 4.382 |
| Date | Value |
|---|---|
| June 30, 2023 | 3.346 |
| March 31, 2023 | 2.560 |
| December 31, 2022 | 2.006 |
| September 30, 2022 | 1.574 |
| June 30, 2022 | 1.081 |
| March 31, 2022 | 0.9068 |
| December 31, 2021 | 0.6782 |
| September 30, 2021 | 0.6068 |
| June 30, 2021 | 0.5566 |
| March 31, 2021 | -3.773 |
| December 31, 2020 | -8.305 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Tandem Diabetes Care, Inc. | 5.670 |
| CVRx, Inc. | 2.976 |
| Accuray, Inc. | 4.410 |
| Orthofix Medical, Inc. | 0.6102 |
| ResMed, Inc. | 0.1254 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 96.99M |
| Total Liabilities (Quarterly) | 85.11M |
| Shareholders Equity (Quarterly) | 11.88M |
| Current Ratio | 4.944 |
| Net Debt Paydown Yield | 0.12% |